Axa
ARIA

Axa’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Axa’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-568,527
Closed -$3.62M – 1512
2014
Q2 		$3.62M Sell
568,527
-11,517
-2% -$79.2K 0.02% 635
2014
Q1 		$4.67M Sell
580,044
-386,940
-40% -$3.01M 0.02% 541
2013
Q4 		$6.59M Buy
966,984
+385,571
+66% +$2.08M 0.03% 466
2013
Q3 		$10.7M Buy
581,413
+63,591
+12% +$1.23M 0.05% 352
2013
Q2 		$9.06M Buy
+517,822
New +$9.18M 0.05% 360

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Axa's ARIA Position: Q3 2014 in Review

Axa sold out of Ariad Pharmaceuticals Inc (ARIA) in Q3 2014, closing a stake of 568,527 shares — an estimated $3.62M sold.

Axa first reported a position in ARIA in Q2 2013 and held it in 5 quarters. The position peaked at $10.7M in Q3 2013. 169 funds tracked by Wall St. Rank hold ARIA as of Q3 2014.

  • Axa reported no remaining Ariad Pharmaceuticals Inc position as of Q3 2014 after selling out during the quarter.
  • Axa sold 568,527 Ariad Pharmaceuticals Inc shares in Q3 2014, an estimated $3.62M.
  • Axa first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
  • Axa's Ariad Pharmaceuticals Inc position peaked at $10.7M in Q3 2013.
  • 169 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q3 2014.

Based on Axa's 13F filing for Q3 2014, filed 13 Nov 2014.